Asthma, Alveoli, and Albuterol: A General Overview of Asthma
By: Jeremy Mesias, PharmD Candidate c/o 2022 It starts with a simple cough or a wheeze. Suddenly, it escalates…
A New Drug Class for Heart Failure—Dapagliflozin’s New Groundbreaking Indication for Heart Failure with Reduced Ejection Fraction (HFrEF)
By: Adrian Wong, PharmD Candidate c/o 2021 On May 5, 2020, the Food and Drug Administration (FDA) announced its approval…
Provider Status: What is it?
By: Katharine Russo, PharmD Candidate c/o 2021 As of July 1, 2000, the Accreditation Council for Pharmacy Education (ACPE)…
The Psychological impact of COVID-19 on Mental Health & Quality of Life
By: Shea Dorsey, PharmD Candidate c/o 2021 COVID-19 has taken a major toll on the mental wellbeing of people…
The State of Pharmacy Advocacy in New York
By: Jeremy Mesias, PharmD Candidate c/o 2022 As we begin another October, we mark the start of American Pharmacist…
New York State and Provider Status
By: Mah Noor, PharmD Candidate c/o 2021 Over the past decade, pharmacists across the nation have joined in a…
Pharmacists for Black Lives
By: Aiša Mrkulić , PharmD Candidate c/o 2022 In fulfilling our vow to uphold the Oath of a Pharmacist,…
Novel agents in the treatment of chronic lymphocytic leukemia
By: Nishanth Viswanath, PharmD Candidate c/o 2022 Introduction Chronic lymphocytic leukemia (CLL) is a hematological malignancy of mature CD5 positive…
A Closer Glance at Mycobacterium Avium Complex (MAC) Infection and Treatment
By: Dana Weinstein, PharmD Candidate c/o 2022 Mycobacterium avium complex (MAC) infection in humans is caused by two main species, Mycobacterium…
Metastatic Breast CancER+ Treatment
By: Lyana Sayilar, PharmD Candidate c/o 2020 Approved on April 17, 2020, tucatinib (TukysaTM) is indicated to aid in the…